Filing Details
- Accession Number:
- 0001209191-17-036114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-30 16:07:18
- Reporting Period:
- 2017-05-25
- Filing Date:
- 2017-05-30
- Accepted Time:
- 2017-05-30 16:07:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589725 | M. Helen Thackray | C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850 | Svp Clinical Development, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-25 | 2,000 | $15.57 | 152,615 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on May 31, 2016.
Billionaire Hedge Funds
